Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma
Clinical trial NCT05994157 · TERMINATED
Trial details
- NCT number
- NCT05994157
- Sponsor
- Y-mAbs Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-21
- Primary completion
- 2025-10-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.